Nathaniel S. Gardiner - Nov 19, 2021 Form 4 Insider Report for ENANTA PHARMACEUTICALS INC (ENTA)

Signature
/s/ Nathaniel S. Gardiner
Stock symbol
ENTA
Transactions as of
Nov 19, 2021
Transactions value $
$0
Form type
4
Date filed
11/23/2021, 06:55 PM
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENTA Common Stock Award $0 +6.8K +12.83% $0.00 59.8K Nov 19, 2021 Direct F1
holding ENTA Common Stock 5.91K Nov 19, 2021 By grantor retained annuity trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTA Stock Option (right to buy) Award $0 +28.4K $0.00 28.4K Nov 19, 2021 Common Stock 28.4K $75.33 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs") under the Enanta Pharmaceuticals, Inc. ("Enanta") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Enanta common stock. The RSUs vest in equal annual installments over four years from the date of grant (November 19, 2021). The restricted stock unit shares that vest will be issued on the first December 1 after the applicable vesting date, subject to withholding of a portion of the vested shares to satisfy tax withholding requirements.
F2 Between April and August 2021, a total of 10,735 shares of common stock were distributed to the reporting person from grantor retained annuity trusts created by the reporting person for the benefit of himself and his two adult children (the "GRATs"). The remaining shares are held by one of the GRATs.
F3 Such option will become exercisable (subject to the optionholder's continued employment) quarterly in substantially equal installments (any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding quarterly period in which a whole share equivalent is accumulated) over four years from the date of grant (November 19, 2021).